Our CEO Konstantinos Antonopoulos presented mk2 Biotechnologies on this year’s ChemSpec Europe in Basel to the wider fine and specialty chemistry audience. The response to our alternative options to conventional active chemicals was significant and stimulated several fruitful discussions.
Support and photographic material by BCNP Consultants is acknowledged.
